PHAXIAM Therapeutics (Nasdaq & Euronext: FR0011471135), today announces the enrolment of the 1st patient in …
![Phage therapy for endocarditis caused by S. aureus](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/pexels-photo-7089401.jpeg?resize=760%2C427&ssl=1)
![Phage therapy for endocarditis caused by S. aureus](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/04/pexels-photo-7089401.jpeg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
PHAXIAM Therapeutics (Nasdaq & Euronext: FR0011471135), today announces the enrolment of the 1st patient in …
Dr Agarwal’s Eye Hospital recently announced that their accomplished research team have been honoured with …
IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial intelligence (AI) driven …
Endovascular Engineering (“E2”), a medical device company focused on the development and deployment of groundbreaking …
India has emerged as the diabetes capital of the world with incidence steadily on the …
Annexin Pharmaceuticals announces that all patients in the first dose group with the lowest dose …
The results of a clinical study of Synchrony Medical’s LibAirty™ Airway Clearance System showed that the …
ALR Technologies SG Ltd. (“ALRT” or the “Company”) (OTCQB: ALRTF), a diabetes management company, announces …
Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new …
The first results from an ongoing independent clinical study at the University of Kent, UK, …